BLTE
Income statement / Annual
Last year (2025), Belite Bio Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Belite Bio Inc's net income was -$77.61 M.
See Belite Bio Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$45.38 M
|
$29.94 M
|
$24.84 M
|
$8.87 M
|
$7.42 M
|
$3.69 M
|
| General & Administrative Expenses |
$38.83 M
|
$10.06 M
|
$6.82 M
|
$3.95 M
|
$2.38 M
|
$2.06 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$38.83 M
|
$10.06 M
|
$6.82 M
|
$3.95 M
|
$2.38 M
|
$2.06 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$84.21 M
|
$40.00 M
|
$31.67 M
|
$12.82 M
|
$9.80 M
|
$5.74 M
|
| Cost And Expenses |
$84.21 M
|
$40.00 M
|
$31.67 M
|
$12.82 M
|
$9.80 M
|
$5.74 M
|
| Interest Income |
$0.00
|
$3.74 M
|
$74.00 K
|
$23.00 K
|
$5.00 K
|
$12.00 K
|
| Interest Expense |
$0.00
|
$20.00 K
|
$25.00 K
|
$16.00 K
|
$0.00
|
$21.00 K
|
| Depreciation & Amortization |
$0.00
|
$449.00 K
|
$399.00 K
|
$198.00 K
|
$30.00 K
|
$17.00 K
|
| EBITDA |
-$84.21 M |
-$35.67 M |
-$31.20 M |
-$12.43 M |
-$9.64 M |
-$5.73 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$6.60 M
|
$3.86 M
|
$45.00 K
|
$173.00 K
|
$131.00 K
|
-$9.00 K
|
| Income Before Tax |
-$77.61 M
|
-$36.14 M
|
-$31.62 M
|
-$12.65 M
|
-$9.67 M
|
-$5.75 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$6.00 K
|
$9.00 K
|
$0.00
|
$0.00
|
$1.00 K
|
| Net Income |
-$77.61 M
|
-$36.14 M
|
-$31.63 M
|
-$12.65 M
|
-$9.67 M
|
-$5.75 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-2.31 |
-1.18 |
-1.19 |
-0.63 |
-0.4 |
-0.62 |
| EPS Diluted |
-2.31 |
-1.18 |
-1.19 |
-0.63 |
-0.4 |
-0.62 |
| Weighted Average Shares Out |
$33.54 M
|
$30.54 M
|
$26.59 M
|
$19.98 M
|
$24.10 M
|
$9.21 M
|
| Weighted Average Shares Out Diluted |
$33.54 M
|
$30.54 M
|
$26.59 M
|
$19.98 M
|
$24.10 M
|
$9.21 M
|
| Link |
|
|
|
|
|
|
